The Rh blood group is a system of proteins on the surface of red blood cells that determines whether your blood type is “positive” or “negative.” When you see a blood type written as A+, O-, or B+, that plus or minus sign refers to the Rh system, specifically whether you carry a protein called the D antigen. It is the most complex of all blood group systems, with 49 known antigens, and it plays a critical role in blood transfusions and pregnancy.
The D Antigen and What Makes You Positive or Negative
The Rh system centers on proteins embedded in the membrane of your red blood cells. Two genes produce these proteins: one creates the RhD protein (which carries the D antigen), and the other creates the RhCE protein (which carries a separate set of antigens called C, c, E, and e). These proteins sit within a small complex on the cell surface, paired with a helper molecule called RhAG that is required for the Rh proteins to reach the membrane at all. This complex exists only on red blood cells, which is why Rh typing is done exclusively through blood testing.
If your red blood cells carry the D antigen, you are Rh-positive. If they don’t, you are Rh-negative. This is the single most important distinction in the Rh system, and it’s the one that shows up on your blood type card. The D antigen is highly immunogenic, meaning it is very effective at triggering an immune response in someone whose blood lacks it. That property is what makes Rh status so important in medicine.
How Rh Status Is Inherited
You inherit one copy of each Rh gene from each parent. The RHD gene can be either present or absent. If you inherit at least one working copy, your red blood cells will produce the D antigen and you’ll be Rh-positive. You need two absent copies (one from each parent) to be Rh-negative. This means two Rh-positive parents can have an Rh-negative child if both carry one silent copy of the gene.
The RHCE gene works differently. Rather than being present or absent, it comes in variants that produce slightly different versions of the C/c and E/e antigens. The specific combination you inherit determines your full Rh profile, which labs can type in detail when needed for complex transfusion matching.
How Common Is Rh-Negative Blood?
Rh-negative blood varies dramatically by population. About 17% of people in Britain are Rh-negative, while in northern India the figure drops to roughly 4.3%. Among East Asian and sub-Saharan African populations, Rh-negative blood is even rarer. Globally, the vast majority of people are Rh-positive.
At the extreme end of rarity is a condition sometimes called “golden blood,” or Rh-null. People with Rh-null blood lack all 49 Rh antigens, not just the D antigen. Fewer than 50 people worldwide have ever been identified with this blood type. Rh-null blood can be donated to patients with rare Rh antibody combinations who would react to almost any other blood, making it even more universally compatible than O-negative. But people who have it face a serious challenge: they can safely receive transfusions only from other Rh-null donors, a nearly impossible match. Most are advised to bank their own blood before any planned surgery and to manage conditions like anemia carefully to avoid needing transfusions at all.
Why Rh Matters in Transfusions
If you are Rh-positive, you can receive red blood cells from either Rh-positive or Rh-negative donors. If you are Rh-negative, you should ideally receive only Rh-negative blood. Receiving Rh-positive blood when you are Rh-negative can cause your immune system to produce antibodies against the D antigen. This may not cause a reaction the first time, but once those antibodies form, any future exposure to Rh-positive blood can trigger a transfusion reaction with symptoms like fever, chills, jaundice, back pain, and in severe cases, kidney failure.
Beyond the D antigen, the other Rh antigens (C, c, E, and e) can also cause transfusion problems. Patients who need repeated transfusions, such as those with sickle cell disease, are often matched for these additional Rh antigens to reduce the risk of developing antibodies over time.
Rh Incompatibility in Pregnancy
The most well-known consequence of Rh status involves pregnancy. When an Rh-negative mother carries an Rh-positive baby (the baby having inherited the D antigen from its father), small amounts of fetal blood can cross into the mother’s circulation during delivery, miscarriage, or certain procedures. As little as 0.1 mL of fetal blood is enough to trigger the mother’s immune system to start producing antibodies against the D antigen.
During a first pregnancy, this sensitization usually happens too late to harm the baby. The initial immune response produces a type of antibody that cannot cross the placenta. The danger comes in subsequent pregnancies. If the mother carries another Rh-positive baby, her immune system remembers the D antigen and rapidly produces a different class of antibody that does cross the placenta. These antibodies attack and destroy fetal red blood cells, causing a condition called hemolytic disease of the fetus and newborn. In mild cases, this leads to anemia and jaundice in the newborn. In severe cases, the fetus can develop dangerous fluid buildup throughout the body when hemoglobin drops far below normal for gestational age.
How Rh Disease Is Prevented
Rh-related pregnancy complications are largely preventable with an injection of anti-D immunoglobulin, commonly known by the brand name RhoGAM. This treatment works by clearing any fetal Rh-positive blood cells from the mother’s system before her immune system can mount a lasting response. It is given to Rh-negative mothers who have not yet developed anti-D antibodies, typically within 72 hours after delivering an Rh-positive baby. Many countries also recommend a routine dose during the third trimester.
The protection is dose-dependent. Higher doses neutralize larger volumes of fetal blood that may have entered the mother’s circulation. Dosing standards vary by country: the U.S. and parts of Europe use 200 to 300 micrograms, while the UK recommends at least 100 micrograms and Australia uses 125 micrograms. This approach has dramatically reduced the incidence of Rh disease since its introduction in the 1960s.
How Rh Typing Is Done
Rh typing is a simple blood test, typically performed alongside ABO typing. The standard method is hemagglutination: a lab mixes a sample of your red blood cells with a solution containing anti-D antibodies. If your cells clump together, you have the D antigen and are Rh-positive. If they don’t, you are Rh-negative. Results are usually available quickly and are part of the routine blood work done during pregnancy, before surgery, or when you donate blood.
When antibodies have already formed, as can happen after a sensitizing pregnancy or a mismatched transfusion, a separate test called an antibody screen detects them in the mother’s or patient’s plasma. This helps clinicians determine whether protective treatment is still an option or whether closer monitoring is needed for the current pregnancy or future transfusions.